Drug discovery

Artificial intelligence
#Artificial intelligence (AI) #Automation #Benchling #Drug discovery #Webinar

Webinar presents your infinite program team with AI

R&D teams don’t need another chatbot. They need a team that can act on their behalf, guided by the scientists who know the science best. The future of R&D removes the toil of day-to-day work and connects the data scattered across your systems and teams. In this webinar, taking place… Read More

#News

Parkinson's disease
#Drug discovery #Lundbeck #Parkinson's

Phase Ib data in advanced Parkinson’s disease released as Phase II trial begins 

Lundbeck has announced results from an open-label Phase Ib trial evaluating Lu AF28996, a novel, investigational, oral prodrug of D1-like/D2-like dopamine receptor agonist, in people with advanced Parkinson’s disease experiencing motor symptoms sub-optimally controlled despite optimised non-invasive antiparkinsonian medication.    The results are being presented at the… Read More

#News

#Drug activity #Drug development #Drug discovery #GPCR

Register now: Improving the predictive power of GPCR assays

The pharmacological behaviour of drugs is determined not only by their intrinsic properties but also by the sensitivity of the biological systems in which they are evaluated. Variations in receptor density and signal transduction efficiency can significantly influence observed drug responses, complicating the translation of in vitro findings to in… Read More

#News

#Contract Research Organisations (CROs) #Drug development #Drug discovery #High throughput screening #Small molecules

Advancing small molecule drug discovery

DDW Editor Reece Armstrong speaks to Dr. Zachary Gurard-Levin, CEO and Founder of Peapod Bio about challenges in small molecule drug discovery and what technologies are advancing this sector.    RA: What are the biggest challenges facing small molecule drug discovery and development?  ZG: The challenge that we… Read More

#Exclusive Content

AI roadmap
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug discovery #Investment

AI investment by life science labs hits a four-year high, study finds

The results of a new study show AI/ML investment jumping after three flat years, with three quarters (76%) of respondents planning to increase spending on technology in the next two years, up from 60% in 2023, 62% in 2024, and 63% in 2025.  However, the leading barrier… Read More

#Business & Investment #Editor's Choice #News

Brain physiology
#Drug development #Drug discovery #Neuroscience #Sleep disorders #Small molecules

Why sleep is the next frontier in brain health 

Michelle L. Mellion, MD, Chief Medical Officer at AstronauTx discusses why small molecules that can restore deep, restorative sleep, could be key to cognitive diseases such as Alzheimer’s.   Sleep is the bedrock of good brain health. For a long time, the focus has been on the quantity of sleep. A large body of evidence has… Read More

#Exclusive Content

#Cell and gene therapy #Cell therapy #Drug discovery #Gene therapy #Webinar

Have you registered for our CGT webinar?

Hosted by Drug Discovery World and supported by Bio-Techne this webinar will explore the advances and challenges taking place within the cell and gene therapy field. You will hear from Hans Schambye CEO at BOOST Pharma, Lucas Arruda, CSO at CuraCell, and Brandon Cieniewicz, Director, Research & Development at CERo… Read More

#News

#Cancer research #Cancer vaccines #Drug development #Drug discovery #Immuno-oncology #Sino Biological

Summit explores advances driving immuno-oncology drug discovery

This digital summit, hosted by DDW and supported by Sino Biological, explores the advances and challenges taking place within the field of immuno-oncology. It will take place on Wednesday, October 21, 2026 at 7am PDT / 10am EDT / 3pm BST / 4pm CEST. Featuring expert presentations and a panel… Read More

#News

#Biologics #Cell Science #Drug discovery #Stability characterisation

Stop settling for the proxy – Why stability tests for biologics should measure intermolecular interactions directly

In this advertorial, Dr John Stenson from Malvern Panalytical explains why we need to move away from using ‘SLS mode’ on DLS instruments to determine B22 stability values for biologics. Reliable stability data: A growing need Stability testing for biologics is undergoing something of a revolution, with the… Read More

#Exclusive Content

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (5-9 October 2026) 

News round-up for 5-9 October, 2026 by Megan Thomas, Multimedia Editor at DDW.  This week’s news roundup covers the upcoming Drug Discovery Innovators & Investors Conference in London, as well as some promising updates in cancer research and immunotherapy, particularly the development of new treatments and how… Read More

#News

#DDII #DDIIeventseries #DDIIUK2026 #Drug development #Drug discovery #Events

Full agenda announced for DDW’s London, UK Conference

DDW has announced the full agenda for its Drug Discovery Innovators & Investors (DDII) London, UK Conference – a full-day, in-person event focused on early-stage drug discovery and development. This event is unique in its focus on early-stage drug discovery and development. From groundbreaking science and technology to regulation, funding and partnership, DDII… Read More

#News

#Cell and gene therapy #Drug development #Drug discovery #Webinar

Webinar – Advances in cell and gene therapy

Hosted by Drug Discovery World and supported by Bio-Techne this webinar will explore the advances and challenges taking place within the cell and gene therapy field. You will hear from Hans Schambye CEO at BOOST Pharma, Lucas Arruda, CSO at CuraCell, and Brandon Cieniewicz, Director, Research & Development at CERo… Read More

#News

#Artificial intelligence (AI) #Automation #Benchling #Drug discovery #Webinar

Webinar explores how AI agents are accelerating R&D

R&D teams don’t need another chatbot. They need a team that can act on their behalf, guided by the scientists who know the science best. The future of R&D removes the toil of day-to-day work and connects the data scattered across your systems and teams. In this webinar, taking place… Read More

#News